Aussie Investors Mull Injunction To Block Ventracor Sale To U.S. Firm
This article was originally published in PharmAsia News
Executive Summary
A group of investors is considering taking Australia's Ventracor to court to block its proposed sale to U.S.-based Orqis Medical. Orqis is believed to be the only bidder for Ventracor, but dissident shareholders say the price offered is much too low. Other shareholders are trying to get the company to recapitalize and raise enough funds to tide Ventracor over until its VentrAssist implantable heart pump gains U.S. approval, expected later this year. (Click here for more